The most popular stocks with hedge funds in the fourth quarter of 2019 were the same stocks that were the most popular with hedge funds in the third quarter, with Microsoft remaining the most widely-held stock among hedge funds. But, as the author of today’s article notes, “More interesting were the several stocks ranking below this group of crowded holdings that enjoyed an especially large surge in hedge fund support during the fourth quarter compared to the previous three-month period.” What three stocks saw a significant jump in interest from hedge funds as 2019 came to a close? CLICK HERE.
If you’re concerned about the potential impact of the coronavirus (and/or any other number of risks) on the markets, the author of today’s article recommends turning to “the only ‘back to basics’ technique I know of that’s never failed to produce huge profits over time.” What is this technique – and what about its “closely related cousin” that’s been shown to generate even more powerful results? CLICK HERE.
While we have likely not even hit the peak of the coronavirus crisis yet, whenever the epidemic does come under control, many expect companies and markets impacted by the deadly virus to bounce back. However, as one fund manager cited in today’s article notes, “Everyone thinks everything is going to bounce if demand comes back, but previous incidents have shown that not every company will benefit the same way”. For three sectors – and specific companies within those sectors – that could face particularly difficult roads to recovery, CLICK HERE.
Uber hasn’t exactly had a smooth ride since its IPO last year, but as today’s article outlines, Wall Street sentiment towards the ride-hailing company has taken a more positive turn recently – and a major reason for this is the prospect that the company, which is currently still losing money, could reach the break-even point (or even profitability) later this year. For more on why “analysts and investors have been jumping back on the Uber ride,” CLICK HERE.
Tesla’s stock, which has more than quadrupled since last summer, would certainly seem to be in a bubble – and now one model is indicating that, based on the magnitude of Tesla’s price run-up over the trailing two years, there is a more than 80% chance that bubble will burst. For more – including why the odds of a Tesla stock crash may be even worse than this model suggests – CLICK HERE.
“The coronavirus has spread seemingly indiscriminately, but its impact on stocks has been more focused,” notes the author of today’s article, who proceeds to identify some potential bargains among some of the stocks that have been pummeled by the virus: airlines, cruise-ship and casino operators, oil companies and more. For more, CLICK HERE.
“Even with the stock market as a whole near record highs, there are plenty of individual stocks that are still trading at bargain-basement valuations,” notes the author of today’s article, who proceeds to highlight three stocks that not only cost less than the market average price-to-earnings ratio, but also pay an above-average dividend yield and are growing faster than the average long-term projected growth rate. For these three stocks, CLICK HERE.
As the number of cases of infection by the novel coronavirus around the world rises, so are shares of a number of biotech companies with exposure to experimental vaccines (as was the case a few years back during the Ebola crisis). For four such biotech stocks – two of which are up over 250% since the beginning of the year – CLICK HERE.
In response to the spread of the new Chinese coronavirus – including its reaching the U.S. – U.S. stocks initially tumbled before rebounding as investors focused on positive earnings news. With more bad news and fear concerning the virus likely on the way, what will the virus’s impact be on the stock market? Today’s article provides a comprehensive look at the virus’s impact on Chinese stocks, China-exposed retailers, travel and gaming stocks, and biotech stocks – as well as what history suggests is coming next, potential buying opportunities from coronavirus-triggered selloffs and more. CLICK HERE.
“A solid growth play is a name that appears poised to not only grow at an above-average rate but also reward investors handsomely over the long run,” notes the author of today’s article, who proceeds to highlight three “Buy-rated stocks flagged by the analysts for their strong long-term growth narratives. On top of this, each boasts substantial upside potential from the current share price.” For these three stocks – including a biopharmaceutical company focused on underserved patient communities – For more, CLICK HERE.